product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-NF-κB p105 (Ser933) (178F3) Rabbit mAb (IHC Specific)
catalog :
4808
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
clone name :
178F3
reactivity :
human, rat
application :
immunohistochemistry, immunohistochemistry - paraffin section
citations: 3
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - paraffin section; rat; 1:50; loading ...; fig 4
Ta M, Schwensen K, Liuwantara D, Huso D, Watnick T, Rangan G. Constitutive renal Rel/nuclear factor-?B expression in Lewis polycystic kidney disease rats. World J Nephrol. 2016;5:339-57 pubmed publisher
  • immunohistochemistry - paraffin section; rat; 1:50; fig 6
Ta M, Rao P, Korgaonkar M, Foster S, Peduto A, Harris D, et al. Pyrrolidine dithiocarbamate reduces the progression of total kidney volume and cyst enlargement in experimental polycystic kidney disease. Physiol Rep. 2014;2: pubmed publisher
Valkov A, Sorbye S, Kilvaer T, Donnem T, Smeland E, Bremnes R, et al. The prognostic impact of TGF-?1, fascin, NF-?B and PKC-? expression in soft tissue sarcomas. PLoS ONE. 2011;6:e17507 pubmed publisher
product information
SKU :
4808S
Product-Name :
Phospho-NF-κB p105 (Ser933) (178F3) Rabbit mAb (IHC Specific)
Size :
50 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H
Applications :
Immunohistochemistry (Paraffin)
Product-Category :
Immunology and Inflammation
Shipping-Temp :
COLD
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
105
Host :
Rabbit
Target :
NFkB-p105 (Ser932) phosphate
Primary-Protein :
NFkB-p105
Alt-Names :
DKFZp686C01211,DNA binding factor KBF1,DNA-binding factor KBF1,EBP-1,KBF1,MGC54151,NF-kappa-B,NF-kappaB,NF-kappabeta,NFKB-p105,NFKB-p50,NFKB1,Nuclear factor NF-kappa-B p105 subunit,Nuclear factor NF-kappa-B p50 subunit,Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1,nuclear factor kappa-B DNA binding subunit,p105,p50
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.